Zhengtuo Zhao

Zhengtuo Zhao is the founder of Jieti Medical (阶梯医疗), a brain–computer interface company — under his leadership it developed China's first invasive BCI system meeting medical-device standards . He is also a researcher at the Chinese Academy of Sciences' Center for Excellence in Brain Science and Intelligence, where he and Dr. Li Xue have discussed the company's forward-looking clinical trial goals in interviews published by Qiming Venture Partners . He has been a recurring speaker at Qiming's events, discussing BCI progress in a 2026 WAIC dialogue with Qiming managing partner Hu Xubo and joining an AI-in-healthcare panel at the firm's RMB fund annual meeting that June . Beyond these appearances in Qiming Venture Partners' coverage, elsewhere's corpus holds no fuller profile of him.